Oxbow Advisors LLC acquired a new position in shares of McKesson Corporation (NYSE:MCK – Free Report) during the second quarter, Holdings Channel reports. The institutional investor acquired 8,724 shares of the company’s stock, valued at approximately $6,592,000.
Several other hedge funds have also modified their holdings of MCK. University of Texas Texas AM Investment Management Co. purchased a new position in McKesson in the fourth quarter valued at $25,000. Swiss RE Ltd. acquired a new position in McKesson during the 4th quarter worth $26,000. State of Wyoming purchased a new stake in McKesson during the 2nd quarter worth about $29,000. Kingdom Financial Group LLC. purchased a new stake in McKesson during the 4th quarter worth about $33,000. Finally, Birchwood Financial Partners Inc. acquired a new stake in McKesson in the 4th quarter valued at about $33,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other McKesson news, Director Bradley E. Lerman sold 301 shares of the firm’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $892.33, for a total transaction of $268,591.33. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Brian S. Tyler sold 8,463 shares of the business’s stock in a transaction that occurred on Tuesday, July 7th. The stock was sold at an average price of $793.56, for a total transaction of $6,715,898.28. Following the sale, the chief executive officer owned 5,919 shares of the company’s stock, valued at $4,697,081.64. This represents a 58.84% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 29,049 shares of company stock valued at $22,530,626 over the last three months. 0.06% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Report on McKesson
McKesson Price Performance
Shares of NYSE MCK opened at $869.73 on Wednesday. The business has a 50-day moving average of $817.06 and a two-hundred day moving average of $843.43. The company has a market capitalization of $101.40 billion, a price-to-earnings ratio of 23.27, a price-to-earnings-growth ratio of 1.71 and a beta of 0.30. McKesson Corporation has a 1 year low of $667.50 and a 1 year high of $999.00.
McKesson (NYSE:MCK – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, beating analysts’ consensus estimates of $9.56 by $0.37. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%.The business had revenue of $105.38 billion for the quarter, compared to the consensus estimate of $103.88 billion. During the same quarter in the prior year, the business posted $8.26 EPS. The business’s revenue for the quarter was up 7.7% on a year-over-year basis. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. As a group, equities research analysts expect that McKesson Corporation will post 44.65 earnings per share for the current year.
McKesson Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Tuesday, September 1st will be paid a $0.94 dividend. This is an increase from McKesson’s previous quarterly dividend of $0.82. This represents a $3.76 annualized dividend and a yield of 0.4%. The ex-dividend date is Tuesday, September 1st. McKesson’s payout ratio is currently 8.78%.
About McKesson
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Recommended Stories
- Five stocks we like better than McKesson
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
